MedElevator Войти в исследования
← Поиск публикаций
Inflammatory bowel diseases · 2026

Clinical features and therapeutic requirements of perianal disease in adult patients with ulcerative colitis: the PERICO study of the ENEIDA registry.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Guasch Montserrat, Calafat Margalida, Gargallo-Puyuelo Carla J, De Francisco Ruth, Moraleja Irene, Vega Pablo, de Castro Luisa, Labarga Fernando, Mesonero Francisco, Castro-Poceiro Jesús, Ponferrada-Díaz Angel, Brunet-Mas Eduard, Sesé Eva, Ramos Laura, Quiñones Marta, Ruiz-Cerulla Alexandra, Castro Beatriz, Zabana Yamile, Iglesias Eva, Latras Irene, Varela Pilar, Ricart Elena, Madero Lucía, Elosua Alfonso, Vicente Laura, Lorente Rufo, Betoré Elena, Roig Cristina, Mañosa Míriam, Domènech Eugeni, PERICO-ENEIDA Study of the GETECCU

Аннотация

BACKGROUND: Perianal disease (PD) may occur in ulcerative colitis (UC), but scarce data on its features, clinical course, and common therapeutic approach are available. Our aim was to describe the prevalence, clinical characteristics and therapeutic requirements of PD among patients with UC.

METHODS: Patients with UC and PD were identified from the ENEIDA registry of GETECCU. Epidemiological, clinical, and therapeutic data were retrospectively gathered and reviewed from medical records.

RESULTS: From a total cohort of 9884 patients with UC, 411 developed PD, leading to an incidence rate of 0.5 cases per 100 person-years. Ninety-one patients (22%) developed PD before being diagnosed with UC. The most common perianal lesions at clinical presentation were fissures (52%), followed by fistulae (44%), and abscesses (39%). In the logistic regression analysis, male gender (OR 1.32 [95% CI, 1.10-1.58]; P = .002) and extra-intestinal manifestations (OR 1.88 [95% CI, 1.39-2.52]; P < .0001) were risk factors for PD, whereas ulcerative proctitis (OR 0.66 [95% CI, 0.51-0.86]; P = .002) was the only protective factor. Surgical techniques were used in 44% of patients with PD, and biologicals were indicated due to PD in 12%. Overall, the rate of PD remission was 91%.

CONCLUSIONS: Approximately 4% of patients with UC develop PD, occurring before the diagnosis of UC in one fourth. PD seems to behave less aggressively than in Crohn's disease, being easily managed conservatively or with perianal surgery and needing biological agents only in a minority of patients.